Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s167608 ◽

2018 ◽

Vol Volume 14 ◽

pp. 1527-1533 ◽

Author(s):

Tingting Che ◽

Xiaochun Teng ◽

Qun Huang ◽

Yanfei Mu ◽

Xianjun Tang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Anxiety Symptoms ◽

Randomized Controlled ◽

Download Full-text

Review for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v1/review2 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Randomized Controlled

Download Full-text

Decision letter for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v3/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Randomized Controlled

Download Full-text

Review for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v2/review1 ◽

2019 ◽

Author(s):

Jingjing Zhang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Randomized Controlled

Download Full-text

Inhaled Insulin Provides Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral AgentsA Randomized Controlled Trial

Archives of Internal Medicine ◽

10.1001/archinte.163.19.2277 ◽

2003 ◽

Vol 163 (19) ◽

pp. 2277 ◽

Author(s):

Stuart R. Weiss

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Inhaled Insulin ◽

Randomized Controlled ◽

Download Full-text

Review for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v2/review3 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Randomized Controlled

Download Full-text

Review for "Glycemic control with add‐on thiazolidinedione or sodium glucose co‐transporter 2 inhibitor in type 2 diabetes mellitus patients after failure of an oral triple antidiabetic regimen: A 24‐week randomized controlled trial"

10.1111/dom.14259/v1/review4 ◽

2020 ◽

Author(s):

Mi-Kyung Kim

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

Review for "Glycemic control with add‐on thiazolidinedione or sodium glucose co‐transporter 2 inhibitor in type 2 diabetes mellitus patients after failure of an oral triple antidiabetic regimen: A 24‐week randomized controlled trial"

10.1111/dom.14259/v1/review3 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

Decision letter for "Glycemic control with add‐on thiazolidinedione or sodium glucose co‐transporter 2 inhibitor in type 2 diabetes mellitus patients after failure of an oral triple antidiabetic regimen: A 24‐week randomized controlled trial"

10.1111/dom.14259/v1/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

Author response for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v2/response1 ◽

2019 ◽

Author(s):

Keiichi Torimoto ◽

Yosuke Okada ◽

Yukiko Goshima ◽

Akemi Tokutsu ◽

Yasunori Sato ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Author Response ◽

Randomized Controlled

Download Full-text

Review for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"

10.1111/dom.13770/v1/review5 ◽

2019 ◽

Author(s):

Werner Waldhaeusl

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Insulin Dose ◽

Randomized Controlled

Download Full-text